Treatment Opportunities in Patients With Metabolic Myopathies

Keyphrases

• Metabolic Myopathy 100%
• Treatment Opportunity 100%
• Enzyme Replacement Therapy 60%
• Metabolic 40%
• McArdle Disease 40%
• Gene Expression 20%
• Therapeutic Potential 20%
• Adult Patients 20%
• Potential Treatments 20%
• Current Treatment 20%
• Treatment Options 20%
• Gene Transcription 20%
• Carbohydrates 20%
• Early Onset 20%
• Precipitating Factors 20%
• Stiffness 20%
• Deficiency Diseases 20%
• Molecular Therapy 20%
• Skeletal muscle 20%
• Gene Therapy 20%
• Multiple acyl-CoA Dehydrogenase Deficiency 20%
• L-carnitine 20%
• New Therapeutics 20%
• Dietary Supplements 20%
• Energy Failure 20%
• Contracture 20%
• Targeted Treatment 20%
• Diet Therapy 20%
• Exercise Therapy 20%
• Pompe Disease 20%
• Myoglobinuria 20%
• Riboflavin 20%
• Citric Acid Cycle 20%
• Carnitine Deficiency 20%
• Exercise-induced Pain 20%
• Chaperone Therapy 20%
• Riboflavin-responsive 20%
• Triheptanoin 20%

Medicine and Dentistry

• Myopathy 100%
• Enzyme Replacement Therapy 60%
• Glycogen Storage Disease Type V 40%
• Riboflavin 40%
• Gene Expression 20%
• Disease 20%
• Symptom 20%
• Supplementation 20%
• Cohort Effect 20%
• Genetic Transcription 20%
• Nutritional Deficiency 20%
• Molecular Therapy 20%
• Skeletal Muscle 20%
• Gene Therapy 20%
• Dietary Supplement 20%
• Contracture 20%
• Diet Therapy 20%
• Citric Acid Cycle 20%
• Carnitine 20%
• Kinesiotherapy 20%
• Myoglobinuria 20%
• Glutaric Acidemia Type 2 20%
• Glycogen Storage Disease Type II 20%
• Pharmacological Treatment 20%
• Carnitine Deficiency 20%
• Triheptanoin 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Myopathy 100%
• Replacement Therapy 60%
• Riboflavin 40%
• Glycogen Storage Disease Type 5 40%
• Disease 20%
• Symptom 20%
• Epidemiology 20%
• Nutritional Deficiency 20%
• Contracture 20%
• Carnitine 20%
• Myoglobinuria 20%
• Multiple Acyl CoA Dehydrogenase Deficiency 20%
• Glycogen Storage Disease Type 2 20%
• Carnitine Deficiency 20%
• Dietary Supplement 20%
• Citrate 20%
• Triheptanoin 20%